These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22747239)

  • 1. Saturable sinusoidal uptake is rate-determining process in hepatic elimination of docetaxel in rats.
    Yoon I; Han S; Choi YH; Kang HE; Cho HJ; Kim JS; Shim CK; Chung SJ; Chong S; Kim DD
    Xenobiotica; 2012 Nov; 42(11):1110-9. PubMed ID: 22747239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated approach of in vivo and in vitro evaluation of the involvement of hepatic uptake organic anion transporters in the drug disposition in rats using rifampicin as an inhibitor.
    Imaoka T; Mikkaichi T; Abe K; Hirouchi M; Okudaira N; Izumi T
    Drug Metab Dispos; 2013 Jul; 41(7):1442-9. PubMed ID: 23640987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans.
    Watanabe T; Kusuhara H; Maeda K; Kanamaru H; Saito Y; Hu Z; Sugiyama Y
    Drug Metab Dispos; 2010 Feb; 38(2):215-22. PubMed ID: 19875501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
    Lau YY; Okochi H; Huang Y; Benet LZ
    Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of saturable hepatic uptake of digoxin and its inhibition by rifampicin.
    Weiss M; Hung DY; Poenicke K; Roberts MS
    Eur J Pharm Sci; 2008 Aug; 34(4-5):345-50. PubMed ID: 18573335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic microsome studies are insufficient to characterize in vivo hepatic metabolic clearance and metabolic drug-drug interactions: studies of digoxin metabolism in primary rat hepatocytes versus microsomes.
    Lam JL; Benet LZ
    Drug Metab Dispos; 2004 Nov; 32(11):1311-6. PubMed ID: 15483198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions.
    Lundquist P; Lööf J; Sohlenius-Sternbeck AK; Floby E; Johansson J; Bylund J; Hoogstraate J; Afzelius L; Andersson TB
    Drug Metab Dispos; 2014 Mar; 42(3):469-80. PubMed ID: 24396146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The elimination of MTC-220, a novel anti-tumor agent of conjugate of paclitaxel and muramyl dipeptide analogue, in rats.
    You F; Hu J; Li X; Li Y
    Cancer Chemother Pharmacol; 2013 Jun; 71(6):1453-62. PubMed ID: 23558944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of hepatic transport and metabolism in the interactions between pravastatin or repaglinide and two rOatp inhibitors in rats.
    Badolo L; Bundgaard C; Garmer M; Jensen B
    Eur J Pharm Sci; 2013 Jul; 49(4):767-72. PubMed ID: 23648783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic uptake of epirubicin by isolated rat hepatocytes and its biliary excretion after intravenous infusion in rats.
    Shin DH; Park SH; Jeong SW; Park CW; Han K; Chung YB
    Arch Pharm Res; 2014 Dec; 37(12):1599-606. PubMed ID: 25373308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Evaluation of Dehydroepiandrosterone Sulfate Potential to Predict Hepatic Organic Anion Transporting Polypeptide Transporter-Based Drug-Drug Interactions.
    Nishizawa K; Nakanishi T; Tamai I
    Drug Metab Dispos; 2017 Feb; 45(2):224-227. PubMed ID: 27934638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humans.
    Marre F; Sanderink GJ; de Sousa G; Gaillard C; Martinet M; Rahmani R
    Cancer Res; 1996 Mar; 56(6):1296-302. PubMed ID: 8640817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport Kinetics, Selective Inhibition, and Successful Prediction of In Vivo Inhibition of Rat Hepatic Organic Anion Transporting Polypeptides.
    Ishida K; Ullah M; Tóth B; Juhasz V; Unadkat JD
    Drug Metab Dispos; 2018 Sep; 46(9):1251-1258. PubMed ID: 29891589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: application of in vitro and ex situ systems.
    Lau YY; Okochi H; Huang Y; Benet LZ
    J Pharmacol Exp Ther; 2006 Feb; 316(2):762-71. PubMed ID: 16258024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic uptake of synthetic chlorogenic acid derivatives by the organic anion transport proteins.
    Schwab D; Herling AW; Hemmerle H; Schubert G; Hagenbuch B; Burger HJ
    J Pharmacol Exp Ther; 2001 Jan; 296(1):91-8. PubMed ID: 11123367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-increasing agent.
    Takeuchi K; Sugiura T; Umeda S; Matsubara K; Horikawa M; Nakamichi N; Silver DL; Ishiwata N; Kato Y
    Drug Metab Dispos; 2011 Jun; 39(6):1088-96. PubMed ID: 21422191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo correlation of hepatic transporter effects on erythromycin metabolism: characterizing the importance of transporter-enzyme interplay.
    Lam JL; Okochi H; Huang Y; Benet LZ
    Drug Metab Dispos; 2006 Aug; 34(8):1336-44. PubMed ID: 16698890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Analyses of the Influence of Parameters Governing Rate-Determining Process of Hepatic Elimination of Drugs on the Magnitudes of Drug-Drug Interactions via Hepatic OATPs and CYP3A Using Physiologically Based Pharmacokinetic Models.
    Yoshikado T; Maeda K; Kusuhara H; Furihata KI; Sugiyama Y
    J Pharm Sci; 2017 Sep; 106(9):2739-2750. PubMed ID: 28495568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tesmilifene, a substrate of CYP3A and an inhibitor of P-glycoprotein, on the pharmacokinetics of intravenous and oral docetaxel in rats.
    Choi YH; Suh JH; Lee JH; Cho IH; Lee MG
    J Pharm Pharmacol; 2010 Aug; 62(8):1084-8. PubMed ID: 20663044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the role of transporters on the hepatic elimination of an LAT1 selective inhibitor JPH203.
    Toyoshima J; Kusuhara H; Wempe MF; Endou H; Sugiyama Y
    J Pharm Sci; 2013 Sep; 102(9):3228-38. PubMed ID: 23712732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.